Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

McCallum, Matthew, Czudnochowski, Nadine, Rosen, Laura E., Zepeda, Samantha K., Bowen, John E., Walls, Alexandra C., Hauser, Kevin, Joshi, Anshu +9 more·2022·Science
DOI 10.1126/science.abn8652

Cited by (535)

Items 401–500 of 535

  1. VCAb: a web-tool for structure-guided exploration of antibodies
    Dongjun Guo, Joseph Chi-Fung Ng, Deborah K. Dunn‐Walters, Franca Fraternali · 2024 · Bioinformatics Advances
  2. Interfacial subregions of SARS-CoV-2 spike RBD to hACE2 affect intermolecular affinity by their distinct roles played in association and dissociation kinetics
    Xiangwu Tang, Jingxian Chen, Lu Zhang, Tao Liu, Min Ding, Yun‐Wen Zheng, Yinghui Zhang · 2024 · Communications Biology
  3. Optimisation of the cultured ELISpot/Fluorospot technique for the selective investigation of SARS-CoV-2 reactive central memory T cells
    Jack R. Jerome, Kirsty Wilson, Joshuah Fialho, Georgia Goodchild, Monica D. Prakash, Charlie McLeod, Peter Richmond, Vasso Apostolopoulos, Katie L. Flanagan, Magdalena Plebanski · 2025 · Frontiers in Immunology
  4. Stealth replication of SARS-CoV-2 Omicron in the nasal epithelium at physiological temperature
    Bárbara F. Fonseca, Rémy Robinot, Vincent Michel, Akram Mendez, Samuel Lebourgeois, Chloé Chivé, Raphaël Jeger‐Madiot, Roshan Vaid, Vincent Bondet, Elizabeth Maloney et al. · 2025 · Journal of Virology
  5. A booster with SARS-CoV-2 vaccines: protection against Omicron infection
    Yuehong Hu, Qiu Sun · 2022 · Signal Transduction and Targeted Therapy
  6. Omicron SARS-CoV-2 Spike-1 Protein’s Decreased Binding Affinity to α7nAChr: Implications for Autonomic Dysregulation of the Parasympathetic Nervous System and the Cholinergic Anti-Inflammatory Pathway—An In Silico Analysis
    Domiziano Doria, Alessandro Davide Santin, Jack A. Tuszyński, David E. Scheim, Maral Aminpour · 2022 · BioMedInformatics
  7. In silico design of miniprotein to inhibit SARS-CoV-2 variant Omicron spike protein
    Jianhua Wu, Hong‐Xing Zhang, Jilong Zhang · 2023 · Physical Chemistry Chemical Physics
  8. Virus neutralization of SARS-CoV-2 Omicron variant BA.2 in those vaccinated with three doses of BNT162b2 or CoronaVac vaccines.
    Malik J. S. Peiris, Samuel M. S. Cheng, Kaimin Chan, Leo L. H. Luk, John Li, Leo C. H. Tsang, Leo L. M. Poon, Chris Ka Pun Mok, Susanna S. Ng, Fanny W.S. Ko et al. · 2022 · Research Square
  9. A broadly neutralising monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV2 variant of concerns
    Rajesh Kumar, Hilal Ahmed Parray, Naveen Narayan, Sonal Garg, Zaigham Abbas Rizvi, Tripti Shrivastava, Sachin Kushwaha, Janmejay Singh, Praveenkumar Murugavelu, Anbalagan Anantharaj et al. · 2022 · Research Square
  10. A Systematic Review on the Emergence of Omicron Variant and Recent Advancement in Therapies
    Ramendra Pati Pandey, Beyau M. Konyak, Mohan Sharma, Shabnam Kharia, Chung-Ming Chang · 2022 · Preprints.org
  11. The Benefits and Costs of U.S. Employer COVID-19 Vaccine Mandates
    Maddalena Ferranna, Lisa Robinson, Daniel Cadarette, Michael Eber, David E. Bloom · 2022 · National Bureau of Economic Research
  12. Molecular fate-mapping of serum antibodies reveals the effects of antigenic imprinting on repeated immunization
    Ariën Schiepers, Marije F. L. van ’t Wout, Allison J. Greaney, Trinity M. Zang, Hiromi Muramatsu, Paulo J.C. Lin, Ying K. Tam, Luka Mesin, Tyler N. Starr, Paul D. Bieniasz et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Nanobodies as Spray and Aerosol Particles: A Breakthrough in Treating Respiratory Viral Infections
    Mujahed I. Mustafa, Ahmed Mohammed · 2023 · Preprints.org
  14. A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
    Jimin Lee, Cameron Stewart, Alexandra Schaefer, Elizabeth M. Leaf, Young‐Jun Park, Daniel E. Asarnow, John M. Powers, Catherine Treichel, Davide Corti, Ralph Steven Baric et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Structural and Energetic Insights into SARS-CoV-2 Evolution: Analysis of hACE2–RBD Binding in Wild-Type, Delta, and Omicron Subvariants
    Can Tang, Cecylia S. Lupala, Ding Wang, Xiangcheng Li, Lei‐Han Tang, Xuefei Li · 2025 · International Journal of Molecular Sciences
  16. SARS-CoV-2 Omicron Variant Spike Glycoprotein Mutation Q954H Enhances Fusion Core Stability
    Nisansala Vithanage, Rifat Hasan Apurba, Hamza Enesi Ozomarisi, Carson J. Bair, Eve L. Sugg, Victor K. Outlaw · 2025 · ACS Chemical Biology
  17. Amino acid residues 655 and 969 in the spike protein of Omicron subvariant BA.1 control use of TMPRSS2 versus Cathepsin L dependent entry pathways and cell tropism
    Cheila Rocha, Prerna Arora, Lu Zhang, Anzhalika Sidarovich, Luise Graichen, Anna-Sophie Moldenhauer, Stefan Pöhlmann, Markus Hoffmann · 2025 · PLoS ONE
  18. Allosteric Control Overcomes Steric Limitations for Neutralizing Antibodies Targeting Conserved Binding Epitopes of the SARS-CoV-2 Spike Protein: Exploring the Intersection of Binding, Allostery, and Immune Escape with a Multimodal Computational Approach
    Mohammed Alshahrani, Vedant Parikh, Brandon Foley, Gennady M. Verkhivker · 2025 · Biomolecules
  19. Mechanisms of Binding and Immune Escape Resistance for Broadly Neutralizing Antibodies Targeting Distinct Conserved SARS-CoV-2 Spike Epitopes: A Hierarchical Approach Integrating Mutational Profiling and Energy Landscape Analysis
    Mohammed Alshahrani, Will Gatlin, Max Ludwick, Lucas Turano, Brandon Foley, Gennady M. Verkhivker · 2026 · International Journal of Molecular Sciences
  20. Analysis of the Transmission of SARS-CoV-2 Delta VOC in Yantai, China, August 2021
    Yulou Sun, Yuwei Zhang, Zimo Liu, Xia Li, Juan Liu, Xinghan Tian, Qiao Gao, Peihua Niu, Hongli Zhai, Zhenlu Sun et al. · 2022 · Frontiers in Medicine
  21. Variantes de SARS-CoV-2 y los casos asociados a cuatro olas epidemiológicas en Sinaloa, México
    Jorge Luis Batista-Roche, Marian Mirabent-Casals, Bruno Gómez‐Gil, César A. Berlanga-Robles, Alejandra Garcı́a-Gasca · 2022 · TIP Revista Especializada en Ciencias Químico-Biológicas
  22. Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS‐CoV‐2
    Hyung J. Kwon, Jun Zhang, Matina Kosikova, Weichun Tang, Uriel Ortega‐Rodriguez, Hanqin Peng, Clement A. Meseda, Cyntia L. Pedro, Falko Schmeisser, Jianming Lu et al. · 2023 · Journal of Medical Virology
  23. What can traditional plant therapy do in the face of Covid-19? Examples from traditional Chinese medicine
    Dandan Song, Qian Deng, Hualiang Chen · 2023 · African Health Sciences
  24. A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants
    Marisa L. Yang, Tom Z. Yuan, Kara Y. Chan, Lin Ding, Zhen Han, Hector Franco, Carson Holliday, Shruthi Kannan, Edgar Davidson, Benjamin J. Doranz et al. · 2024 · Antibody Therapeutics
  25. Engineered bispecific antibodies with enhanced breadth and potency against SARS-CoV-2 variants and SARS-related coronaviruses
    Fangfang Chang, Qian Wu, Yabin Hu, Zhendong Pan, Yongchen Liu, Y W Li, Mihnea Bostina, Wenpei Liu, Ping Zhao, Xiaowang Qu et al. · 2024 · Medical Microbiology and Immunology
  26. Coronaviruses: Pandemic SARS-CoV-2
    Benjamin John Cowling, Sook‐San Wong · 2024 · Springer eBooks
  27. Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants
    Yi Wu, Xiaoying Jia, Namei Wu, Xinghai Zhang, Yan Wu, Yang Liu, Minmin Zhou, Yanqiong Shen, Entao Li, Wei Wang et al. · 2024 · Acta Pharmaceutica Sinica B
  28. COVID-19 vaccination induces cross-neutralisation of sarbecoviruses related to SARS-CoV-2
    Grace E. West, Rebecca B. Morse, Benjamin Louis Sievers, Adam Abdullahi, Kimia Kamelian, Mark T. K. Cheng, John R. Bradley, Stephen Baker, Barbara Graves, Hannah Stark et al. · 2026 · npj Vaccines
  29. Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate
    Meng‐Chun Zhang, Hao Wu, Jiaxing Wang, Meixi Lu, Danli Cao, Jingwen Lin, Hang Chen, Caiji Lin, Yao Wang, Xing-Hua Zhang et al. · 2025 · Virology
  30. An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant
    Ryuta Uraki, Maki Kiso, Mutsumi Ito, Seiya Yamayoshi, Peter Halfmann, Shilpi Jain, Mehul S. Suthar, Tiago J. S. Lopes, Nao Jounai, Kazuki Miyaji et al. · 2025 · EBioMedicine
  31. Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19
    Arjun Puranik, Patrick J. Lenehan, John Charles O’Horo, Colin Pawlowski, Abinash Virk, Melanie D. Swift, Walter K. Kremers, AJ Venkatakrishnan, Douglas W. Challener, Laura E. Breeher et al. · 2022 · PNAS Nexus
  32. Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis
    Haoyue Cheng, Zhicheng Peng, Shuting Si, Xialidan Alifu, Haibo Zhou, Peihan Chi, Yan Zhuang, Minjia Mo, Yunxian Yu · 2022 · Vaccines
  33. SARS-CoV-2 Cellular Entry and Antigen Recognition: Modulating Immunological Responses
    Joseph F Murphy · 2022 · Journal of Immunology Research & Reports
  34. Dynamic Evolution of SARS-CoV-2 in a Patient on Chemotherapy
    Weihua Huang, Changhong Yin, Kimberly P. Briley, William A.B. Dalzell, John T. Fallon · 2023 · Viruses
  35. Mechanistic study of the transmission pattern of the SARS‐CoV ‐2 omicron variant
    Ke An, Xianzhi Yang, Mengqi Luo, Junfang Yan, Peiyi Xu, Honghui Zhang, Yuqing Li, Song Wu, Arieh Warshel, Chen Bai · 2024 · Proteins Structure Function and Bioinformatics
  36. Evaluating mAbs binding abilities to Omicron subvariant RBDs: implications for selecting effective mAb therapies
    Song Luo, Danyang Xiong, Bolin Tang, Bangyu Liu, Xiaoyu Zhao, Lili Duan · 2024 · Physical Chemistry Chemical Physics
  37. Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
    Jean‐Sélim Driouich, Maxime Cochin, Guillaume Lingas, Léa Lucıanı, Cécile Baronti, Ornéllie Bernadin, Magali Gilles, Paola Mariela Saba Villarroel, Grégory Moureau, Paul-Rémi Petit et al. · 2024 · Biomedicine & Pharmacotherapy
  38. Omicron Transmissibility, Severity, Vaccines, and Future Perspectives
    Adil Maqbool, Subrina Jesmin, Nobutake Shimojo, Masao Moroi · 2022 · Microbiology & Infectious Diseases
  39. A CNN model for predicting binding affinity changes between SARS-CoV-2 spike RBD variants and ACE2 homologues
    Chen Chen, Veda Sheersh Boorla, Ratul Chowdhury, Ruth Helmus Nissly, Abhinay Gontu, Shubhada K. Chothe, Lindsey Cecelia LaBella, Padmaja Jakka, Santhamani Ramasamy, Kurt J. Vandegrift et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Potent and specific human monoclonal antibodies against SARS-CoV-2 Omicron variant by rapid mRNA immunization of humanized mice
    Ping Ren, Lei Peng, Zhenhao Fang, Kazushi Suzuki, Paul A. Renauer, Qianqian Lin, Meizhu Bai, Luojia Yang, Tongqing Li, Paul R. Clark et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model
    Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Janina Gergen, Kristina Kovacikova, Kore Schlottau, Nico Joël Halwe, Lorenz Ulrich et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  42. Humanized antibody potently neutralizes all SARS-CoV-2 variants by a novel mechanism
    Sai Luo, Jun Zhang, Alex J.B. Kreutzberger, Amanda Eaton, Robert J. Edwards, Changbin Jing, Hai‐Qiang Dai, Gregory D. Sempowski, Kenneth D. Cronin, Robert Parks et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Evolution to increased positive charge on the viral spike protein may be part of the adaptation of SARS-CoV-2 to human transmission
    Matthew L. Cotten, My V. T. Phan · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi
    Upendo L. Mseka, Jonathan J. Mandolo, Kenneth Nyoni, Oscar Divala, Dzinkambani Moffat Kambalame, Daniel Mapemba, Moses Kamzati, Innocent Chibwe, Marc Henrion, Kingsley Manda et al. · 2022 · medRxiv
  45. Immune response to COVID-19 vaccines in people with immunodeficiencies
    Emily Ricotta, Mackenzie Zendt, Fausto Bustos Castillo, Sophie Kelly, Taylor A. Saturday, Maureen DeGrange, Anita Ginigeme, Lurline Wu, Viviane Callier, Ana Maria Ortega‐Villa et al. · 2023 · Research Square
  46. In silico evaluation of anti SARS-CoV-2 antibodies neutralization power: A blueprint with monoclonal antibody Sotrovimab
    Dana Ashoor, Maryam Marzouq, M. Dahmani Fathallah · 2023 · Research Square
  47. Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake
    Michael L. Mallory, Jennifer E. Munt, Tara M. Narowski, Izabella N. Castillo, Edwing Cuadra, Nora Pisanic, Paul Fields, John M. Powers, Alexandria M. Dickson, Rohan Harris et al. · 2023 · medRxiv
  48. Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein
    Sameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, Wafaa B. Alsoussi, Tamarand L. Darling, Bernadeta Dadonaite, Alesandro Civljak, Stephen C. Horvath, Julian Q. Zhou, Wooseob Kim et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Neutral Frustration Landscape Architecture of SARS-CoV-2 Spike-Antibody Interfaces Shapes Immune Evasion Mechanisms for Ultrapotent Neutralizing Antibodies and Determines Pathways of Viral Adaptation: Insights from Integrative Computational Approach
    Mohammed Alshahrani, Vedant Parikh, Brandon Foley, Gennady M. Verkhivker · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Computational redesign of Beta-27 Fab with substantially better predicted binding affinity to the SARS-CoV-2 Omicron variant than human ACE2 receptor
    Wantanee Treewattanawong, Thassanai Sitthiyotha, Surasak Chunsrivirot · 2023 · Scientific Reports
  51. Characterization of therapeutic antibody efficacy against multiple SARS-CoV-2 variants in the hamster model
    Yu Cong, Saurabh Dixit, Donna L. Perry, Louis Huzella, Erin Kollins, Russell A. Byrum, Scott M. Anthony, David Drawbaugh, Sanae Lembirik, Elena N. Postnikova et al. · 2024 · Antiviral Research
  52. Molecular mechanistic exploration of conformational shifts induced by class IV anti-RBD antibody IY2A
    Enhao Zhang, Song Luo, Xiaole Xu, Qihang Wang, Jinxin Liu, Pengfei Gao, Lili Duan · 2025 · International Journal of Biological Macromolecules
  53. Dihydrotanshinone I targets the spike N-terminal domain to inhibit SARS-CoV-2 entry and spike-induced inflammation
    Chan Yang, Kunyu Lu, Jinshen Wang, Hao Su, Luping Cheng, Chunmei Nong, Xiaoyan Pan, Haobin Li, Zheng Peng, Yinghua Chen et al. · 2025 · Phytomedicine
  54. Evolutionary aspect of spike glycoprotein's conformational dynamics
    Wentao Xu, Tianyu Guo, Haibin Su · 2026 · Physical Chemistry Chemical Physics
  55. RECUR: identifying recurrent amino acid substitutions from multiple sequence alignments
    Elizabeth H J Robbins, Yi Liu, Steven L. Kelly · 2026 · Molecular Biology and Evolution
  56. Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants
    Seth J. Zost, Naveenchandra Suryadevara, Lauren E. Williamson, Suzanne M. Scheaffer, Elad Binshtein, Cameron D. Buchman, Nicole V. Johnson, Nicholas Catanzaro, Silvia Ravera, Nathaniel S. Chapman et al. · 2026 · Nature Microbiology
  57. PRIME: An evaluation framework for protein representation inference and generalization in viral mutation space
    Kaetlyn Gibson, Po‐E Li, Valerie Li, Martha Dix, Li-Wei Hung, George Widgery Stelle, Michal Babinski, Patrick Chain, Bin Hu · 2026 · BMC Genomics
  58. Prototype strains of SARS-CoV-2 genetic lineages identified in the Primorsky Krai during the COVID-19 pandemic (2020–2023)
    M. Shchelkanov, N. Krylova, A. A. Belik, E. V. Persianova, Y. Belov, O. S. Maistrovskaya, Anastasiya A. Mikhalko, M. F. Trofimova, M. N. Prosyannikova, O. B. Romanova et al. · 2026 · Journal of microbiology, epidemiology and immunobiology
  59. Boosting with variant-matched vaccines: an opportunity to win the race against Omicron
    Jiayu Wang, Tianxia Lan, Qiu Sun · 2022 · Signal Transduction and Targeted Therapy
  60. Perspective Chapter: SARS-CoV-2 Variants – Two Years Post-Onset of the Pandemic
    Adekunle O. Sanyaolu, Aleksandra Marinkovic, Stephanie Prakash, Chuku Okorie, Abdul Jan, Priyank Desai, Abu Fahad Abbasi, Jasmine Mangat, Zaheeda Hosein, Kareem A. Hamdy et al. · 2022 · Infectious diseases
  61. Smart Nanostructured Materials for SARS-CoV-2 and Variants Prevention, Biosensing and Vaccination
    Lifeng Wang, Zhi-Wei Li · 2022 · Biosensors
  62. Mucosal immune probiotic vector vaccines: Development and prospects for application in COVID-19
    Renyun Zha, Boyang Yi, Conghui Liao, Xiaokang Li, Jiahai Lu · 2023 · One Health Bulletin
  63. Causes and Consequences of Coronavirus Spike Protein Variability
    F. Zech, C. Jung, Timo Jacob, F. Kirchhoff · 2024 · Viruses
  64. Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method
    Dana Ashoor, Maryam Marzouq, M. Dahmani Fathallah · 2024 · JMIR Bioinformatics and Biotechnology
  65. Characterization of the Pathogenic Features of Multiple SARS‐CoV‐2 Pandemic Strains in Different Mouse Models
    Huize Sun, Kunpeng Liu, Baocheng Yu, Miao Zhu, Lijia Jia, Weitong Yao, Zhen Chen, Haojie Hao, Xueyan Zhang, Yi Liu et al. · 2024 · Journal of Medical Virology
  66. Severe Acute Respiratory Syndrome Coronavirus 2 Epitope Mapping for Antibodies
    Jiaan Yang, Peng Zhang, Wen Xiang Cheng, Gang Wu, Qing Tian Niu, Lan Yang, Shun Luo, Xianghua Lin, Lianshan Zhang · 2022 · ImmunoHorizons
  67. CoVM2: Molecular Biological Data Integration of SARS-CoV-2 Proteins in a Macro-to-Micro Method
    Hongjun Chen, Xiaotian Hu, Yanshi Hu, Jiawen Zhou, Ming Chen · 2022 · Biomolecules
  68. Genome characterization, phylogenomic assessment and spatio-temporal dynamics study of highly mutated BA variants from India
    Poulomi Sarkar, Sarthak Banerjee, Saikat Chakrabarti, Partha Chakrabarti, Arun Bandyopadhyay, Arpita Ghosh Mitra, Soumen Saha, Aviral Roy, Siddik Sarkar · 2022 · Indian Journal of Medical Microbiology
  69. Broad neutralization of SARS-CoV-2 variants by circular mRNA producing VFLIP-X spike in mice
    Chotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, Puttipatch Leelukkanaveera, Pat Lerdwattanasombat, Suwimon Manopwisedjaroen, Nut Phueakphud, Sakonwan Kuhaudomlarp, Eduardo Olmedillas, Erica Ollmann Saphire et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  70. SARS-CoV-2 and its variants, but not Omicron, induces severe thymic atrophy and impaired T cell development
    Zaigham Abbas Rizvi, Srikanth Sadhu, Jyotsna Dandotiya, Akshay Binayke, Puja Sharma, Virendra Singha, Vinayaka Das, Ritika Khatri, Rajesh Kumar, Sweety Samal et al. · 2022 · Research Square
  71. ACE2, a drug target for COVID-19 treatment?
    Yang Liu, Huilian Huang · 2022 · Irish Journal of Medical Science (1971 -)
  72. Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2: A Retrospective Chart Review
    Masaya Yamato, Masahiro Kinoshita, Shogo Miyazawa, Masayuki Seki, Tomoki Mizuno, Takuhiro Sonoyama · 2023 · medRxiv
  73. Impacts of vaccination on the variant selection of SARS-CoV-2 and the subsequent case hospitalization rate: insights from the first U.S. Omicron wave
    Jingbo Liang, Zhaojun Ding, Qingpeng Zhang, Hsiang‐Yu Yuan · 2024 · medRxiv
  74. A Fine-tuned ProtGPT2 (transformer model) for Predicting more Virulent SARS-CoV-2 variants and understanding its virulence by biophysical methods
    Sam Paul Dhamodharan, Abraham Rebairo J., Rashmi Siddalingappa, Venkatachalam Rajakannan B, Gugan Kothandan · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  75. On-Campus Dormitories as Viral Transmission Sinks: Phylodynamic Insights into Student Housing Networks During the COVID-19 Pandemic
    Juan Bolanos, Alex Dornburg, April Harris, Samuel Kunkleman, Jannatul Ferdous, William Taylor, Jessica Ann Schlueter, Cynthia Gibas · 2025 · medRxiv
  76. Cross-Neutralizing Monoclonal Antibodies with Broad Activity Against Human and Bat-Derived SARS-Related Coronaviruses
    Martin Mayora Neto, Kelly da Costa, Diego M. Cantoni, Mariliza Derveni, Edward Wright, Heinz Hoschuetzky, Franz Kaufmann, Petra Schuessler, Nigel James Temperton · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challenges
    Dan Bi Lee, Hyo‐Jin Kim, Ju Hwan Jeong, Ui Soon Jang, You Yeon Chang, Seokbeom Roh, Hyunbum Jeon, Eun Jeong Kim, Su Yeon Han, Jin Young Maeng et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Structural basis of Omicron immune evasion: A comparative computational study of Spike protein-Antibody interaction
    Darshan Contractor, Christoph Globisch, Shiv Swaroop, Alok K. Jain · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Hierarchical Computational Modeling and Dynamic Network Analysis of Allosteric Regulation in the SARS-CoV-2 Spike Omicron Trimer Structures: Omicron Mutations Cooperate to Allosterically Control Balance of Protein Stability and Conformational Adaptability
    Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection
    Jessica Davies, Malick M. Gibani, Greta Portone, Alastair C. McGregor · 2022 · Journal of Infection
  81. Efficacy of antibodies, antivirals, and vaccination on SARS-CoV-2 Omicron Variant
    Rudaina Ismail Osman Ahmed, Shahd S. Salah, Hassan I. Osman · 2022 · International Journal of Research Publications
  82. Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage
    Wen Jiang, Zherui Zhang, Yuhe Zhu, Ben Chen, Chunying Gu, Zhiyan Liu, Xukai Zhang, Hualong Xiong, Yanan Zhang, Bin Zheng et al. · 2022 · Frontiers in Pharmacology
  83. Research Progress of SARS-CoV-2 Omicron Variant
    Kang-Hong Wang · 2022 · Advances in microbiology
  84. Effect of the Graphene Nanosheet on Bio-Functions of the Spike Protein at Open and Closed States: The Comparison Between SARS-CoV-2 WT and Omicron Variant
    Zengshuai Yan, Xiaolei Li, Hong‐Ming Ding, Yu‐qiang Ma · 2022 · SSRN Electronic Journal
  85. Asymptomatic or Symptomatic SARS-CoV-2 Infection Plus Vaccination Confers Increased Adaptive Immunity to Variants of Concern of SARS-CoV-2 Including Omicron
    Peifang Sun, Irene Ramos, Camila H. Coelho, Alba Grifoni, Corey A. Balinsky, Sindhu Vangeti, Alison Tarke, Nathaniel I. Bloom, Vihasi Jani, Silvia Jakubski et al. · 2022 · SSRN Electronic Journal
  86. Preclinial Safety and Efficacy of a Therapeutic Antibody That Targets SARS-CoV-2 at the Sotrovimab Face But is Escaped by Omicron
    Jakob Kreye, S. Momsen Reincke, Stefan Edelburg, Lara Maria Jeworowski, Hans‐Christian Kornau, Jakob Trimpert, Peter Hombach, Sophia Halbe, Volker Nölle, Martin Meyer et al. · 2022 · SSRN Electronic Journal
  87. Atomistic Simulations and Network-Based Energetic Profiling of Binding and Allostery in the SARS-CoV-2 Spike Omicron BA.1, BA.1.1, BA.2 and BA.3 Subvariant Complexes with the Host Receptor: Revealing Hidden Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Long-Range Communication with Allosteric Pockets
    Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Sanger Sequencing for Molecular Diagnosis of SARS-CoV-2 Omicron Subvariants and Its Challenges
    Sin Hang Lee · 2022 · Journal of Biosciences and Medicines
  89. Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against Omicron
    Xiangyang Chi, Lingyun Xia, Guanying Zhang, Ximin Chi, Bangdong Huang, Yuanyuan Zhang, Zhengshan Chen, Jin Han, Liushu Wu, Zeya Li et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Comparative IgG responses to SARS-CoV-2 after natural infection or vaccination
    Kaylan M. Olds, Devon P. Humphreys, Kathleen M. Gavin, Anne L. Wyllie, Timothy A. Bauer · 2022 · medRxiv
  91. Vaccine- and BTI-elicited pre-Omicron immunity more effectively neutralizes Omicron sublineages BA.1, BA.2, BA.4 and BA.5 than pre-Omicron infection alone
    Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, Victor Arendt, Georges Gilson, Thérèse Staub, Carole Seguin‐Devaux, Danielle Perez-Bercoff · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Acoplamiento molecular de metabolitos secundarios que potencialmente inhiben las conformaciones activas de la proteína Spike del virus SARS-COV-2
    Susana Regina Castro Jiménez · 2022
  93. Virus structures and molecular biology exchange glances
    Polly Roy, David Veesler, Felix Augusto Rey · 2023 · Structure
  94. Development of Fully Human, Bispecific Antibodies that Effectively Block Omicron Variant Pseudovirus Infections
    Jason K. Allen, Michelle Gonzalez, Jasbir Kaur, Melinda G. Smith, Junping You, Guojun Yang, Dongxing Zha, Ze Tian, Amin Al-Shami, Chunhua Shi et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  95. SARS-CoV-2: Structure, Pathogenesis, and Diagnosis
    Aarthi Goverdhan · 2023 · Elsevier eBooks
  96. Biological Mechanisms of Transplacental SARS-COV-2 Transmission
    Serena Pirola, Luisa Patanè · 2023 · Springer eBooks
  97. Ensemble-Based Modeling of the SARS-CoV-2 Omicron BA.1 and BA.2 Spike Trimers and Systematic Characterization of Cryptic Binding Pockets in Distinct Functional States : Emergence of Conformation-Sensitive and Variant-Specific Allosteric Binding Sites
    Gennady M. Verkhivker, Mohammed Alshahrani, Grace Gupta · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Accurate Characterization of Conformational Ensembles and Binding Mechanisms of the SARS-CoV-2 Omicron BA.2 and BA.2.86 Spike Protein with the Host Receptor and Distinct Classes of Antibodies Using AlphaFold2-Augmented Integrative Computational Modeling
    Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, Sian Xiao, Peng Tao, Gennady M. Verkhivker · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  99. AlphaFold2-Enabled Atomistic Modeling of Epistatic Binding Mechanisms for the SARS-CoV-2 Spike Omicron XBB.1.5, EG.5 and FLip Variants: Convergent Evolution Hotspots Cooperate to Control Stability and Conformational Adaptability in Balancing ACE2 Binding and Antibody Resistance
    Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, Sian Xiao, Peng Tao, Gennady M. Verkhivker · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Acceptance, safety, and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in patients with primary biliary cholangitis
    Haolong Li, Xu Wang, Siyu Wang, Xinxin Feng, Li Wang, Yongzhe Li · 2024 · Heliyon